Chronic Obstructive Pulmonary Disease Trial Network, Denmark
This trial will investigate whether patiens admitted with an acute exacerbation of chronic obstructive lung disease and pulmonary hypertension will benefit from a targeted pharmacological treatment.
Acute Exacerbation of COPD
Sildenafil
PHASE4
During admittance due to acute exacerbation of chronic obstructive lung disease will patience have an echocardiography to examine their pulmonary pressure. If patient have a tricuspidal return gradient above 40 mmHg, they will receive treatment with a phosphordiesterase-5-inhibitor, Sildenafil.
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 250 participants |
| Masking : | NONE |
| Primary Purpose : | TREATMENT |
| Official Title : | Copd Exacerbation and Pulmonary Hypertension Trial |
| Actual Study Start Date : | 2020-02-01 |
| Estimated Primary Completion Date : | 2024-03-15 |
| Estimated Study Completion Date : | 2024-03-15 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 40 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
Not yet recruiting
Bispebjerg University Hospital
Copenhagen, Denmark,
Not yet recruiting
Herlev-Gentofte Hospital
Copenhagen, Denmark,
Not yet recruiting
Hvidovre Hospital
Copenhagen, Denmark,
Not yet recruiting
North Zealand Hospital
Hillerød, Denmark,
Not yet recruiting
Odense University Hospital
Odense, Denmark,